Skip to main content
. Author manuscript; available in PMC: 2020 Mar 12.
Published in final edited form as: Bioconjug Chem. 2018 Dec 26;30(1):63–69. doi: 10.1021/acs.bioconjchem.8b00720

Figure 2.

Figure 2.

dL5**-cetuximab labels EGFR on fixed HaCaT cells. (A-B) Permeabilized and (C-D) unpermeabilized HaCaT cells labeled with dL5**-cetuximab and MG fluorogen. MG fluorescence is shown on the left, DIC transmitted light images on the right. Scale bars = 50μm.